Skip to main content
. 2017 Jan 31;20(3):541–547. doi: 10.1093/europace/euw389

Table 2.

Clinical comparisons between patients with CPVT1 by pathogenicity of RYR2 variant

Pathogenic /probable pathogenic RYR2 variant RYR2 variant of undetermined /unknown significance
n = 90 n = 27
Male sex 42 (47%) 17 (63%)
Probands 60 (67%) 17 (63%)
Median age at diagnosis (years) 11.7 (8.0–14.7) 11.8 (9.8–14.9)
Median delay to diagnosis (years) 0.5 (0.1–4.1) 0.7 (0.1–4.1)
Syncope 30 (33%) 6 (22%)
Cardiac arrest 33 (37%) 10 (37%)
Atypical trigger for syncope 10 (11%) 3 (11%)
Atypical trigger for cardiac arrest 6 (7%) 2 (7%)
VA 69 (77%) 20 (74%)
Atrial arrhythmia 20 (22%) 6 (22%)
Beta-blocker failure 12 (13%) 3 (11%)
ICD use 46 (51%) 10 (37%)
Deaths 4 (4%) 0 (0%)